Clinical Trials
8 trialsNCT03549000 2024-12-13
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.
Novartis
Phase 1 Terminated
NCT00014131 2023-10-04
Vaccine Therapy in Treating Patients With Kidney Cancer
Lisata Therapeutics, Inc.
Phase 1 Terminated
NCT04382352 2023-03-24
B002-101
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1 Completed
NCT02529930 2022-07-13
An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
Nykode Therapeutics ASA
Phase 1/2 Completed
NCT04436133 2022-05-06
Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
National Vaccine and Serum Institute, China
Phase 2 Completed
NCT01413087 2019-11-01
LAPC-BC-819
Anchiano Therapeutics Israel Ltd.
Phase 2 Terminated
NCT03383952 2017-12-27
A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia
Immune Cell, Inc.
Phase 1 Unknown
NCT03383965 2017-12-27
CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas
Immune Cell, Inc.
Phase 1 Unknown